Akèy › Anplwayè › University of Massachusetts Chan Medical School › Senior PeopleSoft Developer
Senior PeopleSoft Developer nan University of Massachusetts Chan Medical School: Salè H-1B
5 aplikasyon kondisyon travay pou tit travay Senior PeopleSoft Developer nan University of Massachusetts Chan Medical School. Salè baz medyàn ofri $138,682; mwatye mitan $135,000–$138,682.
Demann (LCA)5
Salè medyan ofri$138,682
Mwatye salè yo$135,000–$138,682
10yèm–90yèm pousantaj$133,200–$139,675
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $132,000 |
| FY2024 | 1 | $135,000 |
| FY2025 | 2 | $139,510 |
| FY2026 | 1 | $138,682 |
Aplikasyon
| Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|
| $138,682 E-3 · Nivo II | Worcester, MA | Sep 24, 2025 | Nov 1, 2025 | Certifye |
| $138,682 Nivo II | Worcester, MA | Sep 8, 2025 | Nov 1, 2025 | Certifye |
| $140,337 Nivo II | Worcester, MA | Apr 9, 2025 | Aug 15, 2025 | Certifye |
| $135,000 Nivo IV | Worcester, MA | Jan 5, 2024 | Jan 22, 2024 | Certifye |
| $132,000 E-3 · Nivo IV | Worcester, MA | Sep 18, 2023 | Nov 6, 2023 | Certifye |
Lòt travay nan University of Massachusetts Chan Medical School
- Postdoctoral Associate$61,572
- Resident Physician$83,762
- Instructor$75,644
- Senior Research Scientist$75,000
- Post-Doctoral Associate$62,058
- Assistant Professor$132,000
- Research Associate III$50,000
- Postdoctoral Research Associate$61,008
- Research Associate IV$68,714
- Resident$78,463
- Research Specialist$62,325
- Fellow$92,866
- Biostatistician III$82,000
- Research Scientist, Sr.$76,000
- Sr. Software Engineer$134,723
- Bioinformatician II$63,488
- Research Associate II$44,000
- Clinical Research Coordinator II$49,500
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).